The U.S. Food and Drug Administration (FDA) has cleared ultrasound technology developer SuperSonic Imagine's Aixplorer Mach 30 system. The company has also received the European CE Mark for the device, it said.
Aixplorer Mach 30 features SuperSonic Imagine's ShearWave Plus technology, with offers real-time, quantitative, and reproducible 2D and 3D visualization and evaluation of tissue stiffness. It also includes imaging modes such as Angio Plus for imaging microvascularization of lesions and TriVu, a triplex mode that combines three diagnostic datasets in a single examination, according to the firm.
